For patients and caregivers

Psoriasis clinical trials

Short answer: our physician practices run psoriasis research studies on a rolling basis, meaning studies open and close throughout the year. This page explains what these studies are like and who they may fit. Whether one is open for you right now depends on the specific study, and the first step is always a conversation, never a commitment.

What is psoriasis?

Psoriasis is a long-term condition where the immune system speeds up skin cell growth, causing raised, scaly, often itchy patches called plaques. It is not contagious, it tends to come and go in flares, and for many people it affects confidence as much as skin.

Who might these studies be for?

People whose plaques cover a meaningful area of their body, people whose current treatment is not controlling flares, people who have tried or been denied coverage for biologic medicines, and people who want closer monitoring of their skin. Both new diagnoses and long-time psoriasis patients can fit different studies. One honest boundary: not every person with this condition will qualify, and eligibility always depends on the specific study's criteria.

Is a study open right now?

Studies open and close on a rolling basis, so the honest answer changes month to month. Our dermatology practices in Texas, New Jersey, and New York treat thousands of psoriasis patients, and psoriasis is one of the most active research areas in our network. The fastest way to hear when something matches: join the registry once, and a coordinator contacts you when a fitting study opens, typically before public recruitment begins.

What does it cost, and is there compensation?

Study-related visits, exams, and investigational treatment come at no cost to you, and most studies compensate participants for time and travel. Specific compensation depends on the study and is explained clearly before you decide anything.

What happens after you enquire?

A coordinator contacts you, typically within one to two business days, for a plain-language conversation with no commitment attached. If a study fits, a screening visit follows, after an informed consent you can take home first. Participation is voluntary at every step, you can withdraw at any time for any reason, and your regular medical care never depends on your answer. The full walkthrough is in what happens at your first study visit and are clinical trials safe.

Interested, or just curious?

Both are fine. Join the registry, or email patients@stryderesearch.com with your questions; a real person answers.

Join the registry